think.patient

exp: smid and large cap biopharma, payer | interests: biotech, health policy, tech, investing, poker | not investment advice

[think.patient @ThinkPatient]

@bollox_big7275 @WillyDiBa7 @OnlyInBOS Usually a 12 or 16 oz can (half liter)

[think.patient @ThinkPatient]

@bollox_big7275 @WillyDiBa7 @OnlyInBOS Hard seltzer. Vodka lemonade etc 4-6% ABV

[think.patient @ThinkPatient]

@FastbreakHoops5 EV it all out , wing 3

•Layup: 0.99 × 25,000 = $24,750
•Free throw: 0.90 × 45,000 = $40,500
•Corner 3: 0.40 × 100,000 = $40,000
•Top of key 3: 0.45 × 150,000 = $67,500
•Wing 3: 0.38 × 200,000 = $76,000
•Half-court: 0.05 × 1,000,000 = $50,000

[think.patient @ThinkPatient]

@mattr262 @thats_bb_suzyn @Adobe Stock down in the premarket

[think.patient @ThinkPatient]

@RecessionAlert @grok @runews Lump sum payment = you get paid less than the annuity

Plus taxes

[Martin Shkreli @MartinShkreli]

https://t.co/asNRnIbCcf

[think.patient @ThinkPatient]

@bukoshake72 @houmanhemmati @DrMakaryFDA @FDA Generic meds have little to no margin - lowest bidder is often in markets like India

Branded meds tend to be manufactured in western countries. Higher margin

[think.patient @ThinkPatient]

@RobinKetchum7 @houmanhemmati @DrMakaryFDA @FDA They will post photos of the most egregious ones.

Good luck finding some generics made state side or in the EU

[think.patient @ThinkPatient]

@Rachel308649775 @BillBrewsterTBB His fingers are all over ICER pricing watch dog. In the early years, their reviews tended to be negative (not cost effective)

[think.patient @ThinkPatient]

@canoebrookbl He’s a major funder of ICER (pseudo HTA in the US)

[think.patient @ThinkPatient]

@Biotech2k1 Ibrx has to be one of them

[mike @mike98572986]

$qure $clpt all the bootlickers running around Twitter calling Prasad a man of integrity and all that other hogwash just need to listen to this. It wasn’t just big pharma that hated this guy, his fellow co-workers wanted nothing to do with him. Why has only 1 person from the fda defended this guy, Makary, everyone else thinks this guy is the lowest of the low as an actual human being. This has nothing to do with approving drugs or not approving drugs, this has to do with thinking you are the smartest guy in the room and only your opinion matters.

He isn’t a king, that is not how this works. The guy didn’t know how to play nice in the sandbox with the other kids therefore all the other kids said he has to go. This is why he is in a lab by himself and talks to himself on his podcast. Because the guy cannot get along at all with others and therefore you completely disqualify yourself for being in a leadership role. No leader in any organization will say this is the type of leader they want at their organization. That isn’t how an organization like the FDA works or any organization that is going to be a functional workplace.

[think.patient @ThinkPatient]

@JeromeAdamsMD @venkmurthy I’ll bet he won’t reply to you here

[think.patient @ThinkPatient]

@venkmurthy This is a bad take..

“Champions of rigor” - many would disagree. There’s the real world vs what you read in a text book

[think.patient @ThinkPatient]

@Playteaux1 Can’t wait for family guy’s animated version of this clip

[think.patient @ThinkPatient]

@JackMan724444 Also the sector/ peer companies not doing well this week (and some earnings)

[think.patient @ThinkPatient]

@Biohazard3737 Not really, a lot of battle royale type of games are popular now

Closest I can think of are
Halo multiplayer
Team fortress 2 - already almost 2 decades old

Apex legends is free and has a death match like mode but steep learning curve

[think.patient @ThinkPatient]

@A_May_MD Step 2.5 Call it innovative medicine

[think.patient @ThinkPatient]

@BiotechK33 @daphnezohar They say they are pro external controls but impose unrealistic standards that companies cannot meet. Many of the natural history datasets are from non profits where the company has no control over data standards and design

[think.patient @ThinkPatient]

@RNAiAnalyst Disgusting pay to play